Watchlist Price Alert

Edwards Lifesciences Corp... (EW)

NYSE: EW · Real-Time Price · USD

74.94

-0.17 (-0.23%)

At close: May 06, 2025, 2:07 PM

Edwards Lifesciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	5.44B	6B	5.38B	5.23B	4.39B	4.35B	3.72B	3.44B	2.96B
Cost of Revenue	1.12B	1.38B	1.08B	1.25B	1.08B	1.11B	939.4M	875.3M	797.4M
Gross Profit	4.32B	4.63B	4.3B	3.98B	3.31B	3.23B	2.78B	2.56B	2.17B
Operating Income	1.38B	1.53B	1.75B	1.35B	1.63B	1.15B	748.2M	1.02B	783.8M
Interest Income	120.3M	67.2M	35.5M	17.4M	23.4M	11.5M	32M	20.3M	10.8M
Pretax Income	1.55B	1.6B	1.77B	1.7B	916.7M	1.17B	761.4M	1.03B	737.9M
Net Income	4.17B	1.4B	1.52B	1.5B	823.4M	1.05B	722.2M	622.1M	569.5M
Selling & General & Admin	1.79B	1.82B	1.57B	1.49B	1.23B	1.24B	1.09B	984.7M	904.7M
Research & Development	1.05B	1.07B	945.2M	903.1M	760.7M	752.7M	622.2M	552.6M	443.3M
Other Expenses	101.1M	194.5M	2.6M	12.7M	11.5M	8.2M	4M	-8.2M	-4.9M
Operating Expenses	2.94B	3.09B	2.51B	2.4B	1.99B	1.99B	1.71B	1.54B	1.35B
Interest Expense	19.8M	17.6M	19.2M	18.4M	15.8M	20.7M	29.9M	2.9M	8.4M
Selling & Marketing Expenses	n/a	1.2M	1.1M	-300K	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	4.06B	4.47B	3.59B	3.65B	3.07B	3.11B	2.65B	2.41B	2.15B
Income Tax Expense	152.1M	198.7M	245.5M	198.9M	93.3M	119.6M	39.2M	412.8M	168.4M
Shares Outstanding (Basic)	597.7M	606.7M	619M	623.3M	622.6M	624.9M	627.6M	632.7M	639M
Shares Outstanding (Diluted)	599.3M	609.4M	624.2M	631.2M	631.9M	636.6M	640.8M	647.7M	653.4M
EPS (Basic)	6.98	2.31	2.46	2.41	1.32	1.68	1.15	0.98	0.89
EPS (Diluted)	6.97	2.30	2.44	2.38	1.30	1.64	1.13	0.96	0.87
EBITDA	1.72B	1.77B	1.96B	1.86B	1.07B	1.31B	872.2M	1.1B	827.1M
EBIT	1.57B	1.62B	1.79B	1.72B	938.9M	1.19B	791.3M	1.06B	757.1M
Depreciation & Amortization	155.2M	144.9M	166.8M	163.3M	135.4M	114.6M	77.4M	81.9M	71.2M